| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:44 UTC |
|---|
| HMDB ID | HMDB0014751 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Amodiaquine |
|---|
| Description | Amodiaquine is only found in individuals that have used or taken this drug. It is a 4-aminoquinoquinoline compound with anti-inflammatory properties. [PubChem]The mechanism of plasmodicidal action of amodiaquine is not completely certain. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites. The drug binds the free heme preventing the parasite from converting it to a form less toxic. This drug-heme complex is toxic and disrupts membrane function. |
|---|
| Structure | CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1 InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23) |
|---|
| Synonyms | | Value | Source |
|---|
| Amodiaquina | ChEBI | | Amodiaquinum | ChEBI | | Amodiaquin | HMDB | | Amodiaquine usp24 | HMDB | | Amodiaquine, ring-closed | HMDB | | Camoquin | HMDB | | Flavoquine | HMDB | | Hydrochloride, amodiaquine | HMDB | | Roussel brand OF amodiaquine hydrochloride | HMDB | | Amodiachin | HMDB | | Amodiaquine hydrochloride | HMDB | | Camoquine | HMDB |
|
|---|
| Chemical Formula | C20H22ClN3O |
|---|
| Average Molecular Weight | 355.861 |
|---|
| Monoisotopic Molecular Weight | 355.145140048 |
|---|
| IUPAC Name | 4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol |
|---|
| Traditional Name | amodiaquine |
|---|
| CAS Registry Number | 86-42-0 |
|---|
| SMILES | CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1 |
|---|
| InChI Identifier | InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23) |
|---|
| InChI Key | OVCDSSHSILBFBN-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 4-aminoquinolines. These are organic compounds containing an amino group attached to the 4-position of a quinoline ring system. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Quinolines and derivatives |
|---|
| Sub Class | Aminoquinolines and derivatives |
|---|
| Direct Parent | 4-aminoquinolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Chloroquinoline
- Haloquinoline
- 4-aminoquinoline
- Aminophenol
- P-aminophenol
- Phenylmethylamine
- Benzylamine
- Aniline or substituted anilines
- Aminopyridine
- Phenol
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Aryl chloride
- Monocyclic benzene moiety
- Aryl halide
- Pyridine
- Benzenoid
- Heteroaromatic compound
- Tertiary amine
- Tertiary aliphatic amine
- Secondary amine
- Azacycle
- Amine
- Organochloride
- Organohalogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 208 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0088 g/L | Not Available | | LogP | 3.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.33 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.6704 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.99 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 66.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1188.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 196.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 110.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 148.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 57.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 348.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 355.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 206.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 668.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 49.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 709.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 169.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 245.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 425.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 405.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 51.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Amodiaquine,1TMS,isomer #1 | CCN(CC)CC1=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=CC=C1O[Si](C)(C)C | 3190.0 | Semi standard non polar | 33892256 | | Amodiaquine,1TMS,isomer #2 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C)=CC=C1O | 3023.9 | Semi standard non polar | 33892256 | | Amodiaquine,2TMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3024.2 | Semi standard non polar | 33892256 | | Amodiaquine,2TMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2938.5 | Standard non polar | 33892256 | | Amodiaquine,2TMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3483.6 | Standard polar | 33892256 | | Amodiaquine,1TBDMS,isomer #1 | CCN(CC)CC1=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=CC=C1O[Si](C)(C)C(C)(C)C | 3389.3 | Semi standard non polar | 33892256 | | Amodiaquine,1TBDMS,isomer #2 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C(C)(C)C)=CC=C1O | 3230.9 | Semi standard non polar | 33892256 | | Amodiaquine,2TBDMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3397.2 | Semi standard non polar | 33892256 | | Amodiaquine,2TBDMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3353.8 | Standard non polar | 33892256 | | Amodiaquine,2TBDMS,isomer #1 | CCN(CC)CC1=CC(N(C2=CC=NC3=CC(Cl)=CC=C23)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3619.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Amodiaquine GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-5039000000-deb48fd096e8eab87805 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Amodiaquine GC-MS (1 TMS) - 70eV, Positive | splash10-03di-7009800000-7089f4eec8e0b64bba2c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Amodiaquine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Amodiaquine LC-ESI-qTof , Positive-QTOF | splash10-0570-3940000000-2d4500c74767ebc68cf0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amodiaquine LC-ESI-qTof , Positive-QTOF | splash10-001i-1390000000-e476bc93f0f2236bccdc | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amodiaquine , positive-QTOF | splash10-0570-3940000000-2d4500c74767ebc68cf0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amodiaquine , positive-QTOF | splash10-001i-1390000000-e476bc93f0f2236bccdc | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 10V, Positive-QTOF | splash10-0a4i-0039000000-62adbcf1b80da6582ca1 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 20V, Positive-QTOF | splash10-001i-1393000000-c73e48e7cfd7d390ddfa | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 40V, Positive-QTOF | splash10-0kcs-2190000000-8de404d259f2e431ba08 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 10V, Negative-QTOF | splash10-0udi-1009000000-c665029b31d3d0ae731b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 20V, Negative-QTOF | splash10-0udi-4119000000-d9ade9d08becc9d7fe95 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 40V, Negative-QTOF | splash10-00dl-9111000000-e7bdd6a9f825f1429a1e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 10V, Positive-QTOF | splash10-0a59-0089000000-228889052bdf8049fae3 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 20V, Positive-QTOF | splash10-001i-0090000000-d45ee7ba1c5cd27865fa | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 40V, Positive-QTOF | splash10-053r-0290000000-333fe4ea622efd6132be | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 10V, Negative-QTOF | splash10-0udi-0019000000-398809cbbc619aca8878 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 20V, Negative-QTOF | splash10-0f89-1089000000-3e1ecc2c9b62f8073845 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amodiaquine 40V, Negative-QTOF | splash10-00lr-2290000000-6c33a84366a5268dd9dd | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Harrison AC, Kitteringham NR, Clarke JB, Park BK: The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochem Pharmacol. 1992 Apr 1;43(7):1421-30. [PubMed:1567466 ]
- Jewell H, Maggs JL, Harrison AC, O'Neill PM, Ruscoe JE, Park BK: Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine. Xenobiotica. 1995 Feb;25(2):199-217. [PubMed:7618347 ]
|
|---|